C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 401/12 (2006.01) A61K 31/506 (2006.01) A61P 25/16 (2006.01) C07D 417/12 (2006.01)
Patent
CA 2527093
Compounds represented by Formula (I) or pharmaceutically acceptable salts thereof, are effective as NMDA NR2B antagonists useful for treating conditions such as, for example, Parkinson~s disease, Alzheimer~s disease, migraine, epilepsy and pain.
L'invention concerne des composés représentés par la formule (I) ou leurs sels pharmaceutiquement acceptables, lesquels sont efficaces en tant qu'antagonistes de NMDA NR2B utiles pour traiter des états tels que, par exemple, la maladie de Parkinson, la maladie d'Alzheimer, la migraine, l'épilepsie et la douleur.
Claiborne Christopher F.
Claremon David A.
Liverton Nigel J.
Mccauley John A.
Merck & Co. Inc.
Merck Sharp & Dohme Corp.
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
3-fluoro-piperidines as nmda/nr2b antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 3-fluoro-piperidines as nmda/nr2b antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 3-fluoro-piperidines as nmda/nr2b antagonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1549209